









Markets
/
Stocks
/
nasdaq-imdx
/

Insight Molecular Diagnostics Ord Shs

IMDX

5.020USD

-0.195-3.74%

Close 12/15, 16:00（ET）Quotes delayed by 15 min

143.70MMarket Cap

LossP/E TTM



Insight Molecular Diagnostics Ord Shs

5.020

-0.195-3.74%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of Insight Molecular Diagnostics Ord Shs here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

Total equity

Cash, cash equivalents and short-term investments

--18.69M

- Cash and cash equivalents

--18.69M

Receivables

--258.00K

-Accounts and notes receivable

--258.00K

Inventory

--471.00K

Prepaid expenses

--1.24M

Other current assets

--729.00K

Total current assets

--21.39M

Non-current assets

Net Fixed Assets

--6.49M

Goodwill and other intangible assets

--14.60M

Other non-current assets

--1.46M

Total non-current assets

--22.55M

Total assets

--43.94M

Liabilities

Current liabilities

Accrued expenses

--5.01M

Short-term debt and lease liabilities

--507.00K

-Short-term lease liabilities

--507.00K

Total current liabilities

--7.66M

Non-current liabilities

Long-term debt and lease liabilities

--1.04M

-Long-term lease liabilities

--1.04M

Other non-current liabilities

--43.94M

Total non-current liabilities

--45.47M

Total liabilities

--53.13M

Shareholders' equity

Common equity

--368.52M

Retained earnings

---377.81M

Gains losses not affecting retained earnings

--86.00K

Total equity

---9.20M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

